EP1218025A4 - USE OF MULLER INHIBITING SUBSTANCE FOR THE TREATMENT OF ANDROGEN OVERHEAD STATE - Google Patents

USE OF MULLER INHIBITING SUBSTANCE FOR THE TREATMENT OF ANDROGEN OVERHEAD STATE

Info

Publication number: EP1218025A4
Authority: EP; European Patent Office
Prior art keywords: androgen; muller; treatment; inhibiting substance; overhead state
Prior art date: 1999-09-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00963414A

Other languages

German (de)

French (fr)

Other versions

EP1218025A1 (en

Inventor

Patricia K Donahoe

Jose Teixeira

Eric Fynn-Thompson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

General Hospital Corp

Original Assignee

General Hospital Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-14

Filing date

2000-09-14

Publication date

2005-06-01

2000-09-14 Application filed by General Hospital Corp filed Critical General Hospital Corp

2002-07-03 Publication of EP1218025A1 publication Critical patent/EP1218025A1/en

2005-06-01 Publication of EP1218025A4 publication Critical patent/EP1218025A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EP00963414A 1999-09-14 2000-09-14 USE OF MULLER INHIBITING SUBSTANCE FOR THE TREATMENT OF ANDROGEN OVERHEAD STATE Withdrawn EP1218025A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US15367499P	1999-09-14	1999-09-14
US153674P		1999-09-14
US15394099P	1999-09-15	1999-09-15
US153940P		1999-09-15
PCT/US2000/025094 WO2001019387A1 (en)	1999-09-14	2000-09-14	Use of mullerian inhibiting substance for treating excess androgen states

Publications (2)

Publication Number	Publication Date
EP1218025A1 EP1218025A1 (en)	2002-07-03
EP1218025A4 true EP1218025A4 (en)	2005-06-01

Family

ID=26850750

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00963414A Withdrawn EP1218025A4 (en)	1999-09-14	2000-09-14	USE OF MULLER INHIBITING SUBSTANCE FOR THE TREATMENT OF ANDROGEN OVERHEAD STATE

Country Status (5)

Country	Link
EP (1)	EP1218025A4 (en)
JP (1)	JP2003509377A (en)
AU (1)	AU7483000A (en)
CA (1)	CA2384991A1 (en)
WO (1)	WO2001019387A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11084860B2 (en) *	2013-03-12	2021-08-10	The General Hospital Corporation	Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
AU2014321760A1 (en)	2013-09-20	2016-05-05	Massachusetts Eye And Ear Infirmary	Uses of modified mullerian inhibiting substance (MIS) proteins for the treatment of neurodegenerative diseases
EP4008339A1 (en)	2013-12-11	2022-06-08	The General Hospital Corporation	Use of mullerian inhibiting substance (mis) proteins for contraception
WO2018112168A1 (en)	2016-12-14	2018-06-21	The General Hospital Corporation	Mullerian inhibiting substance (mis) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5047336A (en) *	1985-10-30	1991-09-10	Biogen, Inc.	DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides
US5427780A (en) *	1985-10-30	1995-06-27	Biogen, Inc.	Composition comprising Mullerian inhibiting substance-like polypeptides
US5484768A (en) *	1990-05-16	1996-01-16	The University Of Melbourne	Treatment of male infertility by administration of a muellerian inhibiting substance and surgery and/or hormonal treatment
AU3920693A (en) *	1992-03-18	1993-10-21	General Hospital Corporation, The	Four novel receptors of the TGF-beta receptor family
JP2947938B2 (en) *	1994-11-28	1999-09-13	旭化成工業株式会社	Optical recording medium

2000
- 2000-09-14 CA CA002384991A patent/CA2384991A1/en not_active Abandoned
- 2000-09-14 AU AU74830/00A patent/AU7483000A/en not_active Abandoned
- 2000-09-14 EP EP00963414A patent/EP1218025A4/en not_active Withdrawn
- 2000-09-14 WO PCT/US2000/025094 patent/WO2001019387A1/en not_active Ceased
- 2000-09-14 JP JP2001523019A patent/JP2003509377A/en active Pending

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0119387A1 *

Also Published As

Publication number	Publication date
JP2003509377A (en)	2003-03-11
WO2001019387A1 (en)	2001-03-22
CA2384991A1 (en)	2001-03-22
EP1218025A1 (en)	2002-07-03
AU7483000A (en)	2001-04-17

Publication	Publication Date	Title
DE60019556D1 (en)	2005-05-25	2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DE60019555D1 (en)	2005-05-25	2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DE50009504D1 (en)	2005-03-17	USE OF RETIGABIN FOR THE TREATMENT OF NEUROPATHIC PAIN
ATE275145T1 (en)	2004-09-15	CHINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMORS
ATE417602T1 (en)	2009-01-15	AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS
DE69934877D1 (en)	2007-03-08	BIOCHANINE-ENRICHED EXTRACT FOR THE TREATMENT OF ESTROGEN-DEPENDENT ILLNESSES
DE60028358D1 (en)	2006-07-06	HMG1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION
DE60045386D1 (en)	2011-01-27	DEVICE FOR THE THERMAL TREATMENT OF BELTS
DE60019158D1 (en)	2005-05-04	NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF HERZARRYTHMIES
DE69929996D1 (en)	2006-04-27	PHARMACEUTICAL AGENT FOR THE TREATMENT OF DIABETES
ATE269303T1 (en)	2004-07-15	ARYLPIPERAZINYL-CYCLOHEXYL INDOLE DERIVATIVES FOR THE TREATMENT OF DEPRESSION
DE10082139T1 (en)	2001-10-04	Composition for the treatment of friction pairs
DE60136477D1 (en)	2008-12-18	RETINOIDES FOR THE TREATMENT OF EMPHYSEM
DE60030554T8 (en)	2008-01-10	USES OF ET743 FOR THE TREATMENT OF CANCER
ATE279386T1 (en)	2004-10-15	RETINOIDS FOR THE TREATMENT OF EMPHYSEMA
DE69943089D1 (en)	2011-02-10	METHOD FOR THE TREATMENT OF STAPHYLOKOCKSINFECTIONS
DE69905214D1 (en)	2003-03-13	Agents for the treatment of osteoporosis
DE60027429D1 (en)	2006-05-24	DIHYDROBENZODIAZEPINES AND THEIR USE FOR THE TREATMENT OF DYSLIPIDIA
ATE273276T1 (en)	2004-08-15	CYCLOBUTENDIONE DERIVATIVES FOR THE TREATMENT OF ARTHEROSCLERosis
DE60018200D1 (en)	2005-03-24	USE OF PULLEOMUTILINE DERIVATIVES FOR THE TRANSDERMAL TREATMENT OF BACTERIAL DISEASES
DE60233740D1 (en)	2009-10-29	BENZOEQUECHINOLINE DERIVATIVES FOR THE TREATMENT OF GLAUCOM AND SHORT-TERM
DE60021252D1 (en)	2005-08-18	ANTICONVULSIVA FOR THE TREATMENT OF AUTISM
DE60001255D1 (en)	2003-02-27	Composition for the treatment of polyester fiber
EP1218025A4 (en)	2005-06-01	USE OF MULLER INHIBITING SUBSTANCE FOR THE TREATMENT OF ANDROGEN OVERHEAD STATE
DE60023555D1 (en)	2005-12-01	METHOD FOR THE TREATMENT OF TISSUE

Legal Events

Date	Code	Title	Description
2002-05-17	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-07-03	17P	Request for examination filed	Effective date: 20020415
2002-07-03	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-07-03	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2005-06-01	A4	Supplementary search report drawn up and despatched	Effective date: 20050418
2011-09-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-10-12	18D	Application deemed to be withdrawn	Effective date: 20110401